Skip to main content

Table 1 Baseline patient characteristics

From: A prospective study examining cachexia predictors in patients with incurable cancer

Patient characteristics (n = 628)
Median Age at inclusion (IQR) 65 (17)
Gender f (%)
 Female 359 (57)
 Male 269 (43)
Geographical region f (%)
 Europe 578 (92)
 Canada 43 (7)
 Australia 7 (1)
Cancer type f (%)
 Low risk cancer 184 (29)
  Breast 171 (27)
  Haematological 13 (2)
 Neutral risk cancer 410 (65)
  Lung 125 (20)
  Colorectal 70 (11)
  Prostate 48 (8)
  Female genitalia 36 (6)
  Head and neck 24 (5)
  Urinary 20 (3)
  Hepatobiliary 17 (3)
  Sarcoma, connective and soft tissue 17 (3)
  Small intestine 11 (2)
  Oesophageal 8 (1)
  Other 34 (5)
 High risk cancer 33 (5)
  Pancreatic 24 (4)
  Gastric 9 (1)
Cancer stage f (%)
 Local 83 (13)
 Metastatic/disseminated 543 (87)
 Treatment setting
 Inpatients 56 (9)
 Outpatients 483 (78)
 Home care 77 (13)
Anti-cancer treatment
 Chemotherapy 337 (54)
 Hormonal therapy 81 (13)
 Radiotherapy 35 (6)
 Other 47 (7)
 No treatment 173 (28)
 Median Karnofsky PS (IQR) 70 (10)
Weight loss (6 months) f (%)
  < 1% 535 (85)
 1–5% 93 (15)
 Mean BMI (SD) 25.5 (4.5)
Comorbidities f (%)
 Heart disease 165 (26)
 COPD 62 (10)
 Arthritis 51 (8)
 Renal disease 17 (3)
  1. Abbreviations: IQR interquartile range, PS performance status, SD standard deviation, COPD chronic obstructive pulmonary disease